Targeted and syndromic molecular solutions for clinical utility based on your patient testing


Find the right test, for the right patient, at the right time with our FDA-cleared assays and expanding test menu.


Healthcare-Associated Infections • Simplexa® • Simplexa® • Simplexa®


Respiratory • Simplexa® • Simplexa® • Simplexa® • Simplexa® • Simplexa® • Simplexa®


Bordetella Direct Kit COVID-19 Direct Kit Now, FDA cleared!


COVID-19 & Flu A/B Direct Kit Now, FDA cleared! Flu A/B & RSV Direct Gen II Kit Group A Strep Direct Kit


SARS-CoV-2 Variants Direct Kit (RUO)2


Candida auris Direct Kit (In Development)1 C. difficile Direct Kit


MRSA Direct Kit (In Development)1


Herpes Viruses • Simplexa® • Simplexa®


HSV 1 & 2 Direct Kit (Swab) VZV Swab Direct Kit


Meningitis/Encephalitis • Simplexa® • Simplexa®


Now, FDA cleared! • Simplexa® GBS Direct Kit


HSV 1 & 2 Direct Kit (CSF) VZV Direct Kit (CSF)


Women’s/Neonatal Health • Simplexa®


Congenital CMV Direct Kit


VERIGENE® VERIGENE® VERIGENE® VERIGENE®


Enteric Pathogens Test


Gram-Negative Blood Culture Test Gram-Positive Blood Culture Test Respiratory Pathogens Flex Test


rapid FDA-cleared molecular targeted test for respiratory: Simplexa®


Prepare yourself for this winter season with the most COVID-19 & Flu A/B Direct assay.


To learn more, contact us at cs.molecular@diasorin.com or info@luminexcorp.com.


For In Vitro Diagnostic Use. Products are region specific and may not be approved in some countries/regions. 1. This assay is under development and not currently FDA cleared for IVD use.


2. RUO - This product is for Research Use Only. Not for use in diagnostic procedures. Simplexa, LIAISON MDX, and the associated logos are all trademarks or registered trademarks of DiaSorin Molecular LLC, or its affiliate, in the U.S. and/ or other countries. Luminex and VERIGENE are trademarks of Luminex Corporation, registered in the US and other countries. ©2023 DiaSorin Molecular LLC. All rights reserved.


PRTA620782 .0823


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48